ResearcherNiğde Ömer Halisdemir ÜniversitesiActive in the last 2 years

Meltem Uyaner Kan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9478-578X; OpenAlex author ID A5033218278. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2026: 2 papers

Papers 2

NECTIN4 (PVRL4) expression in pancreatic cancer patients might be associated with a more unfavorable prognosis, independent of age at diagnosis, sex, and stage… First author DOI 10.1016/j.compbiolchem.2026.109306 ↗
Exploratory Multi-Platform Bioinformatic Analysis of MEAK7 and Its Molecular, Survival, and Immune Associations in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/ijms27177610 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Fatih Yay · 1 shared paper, 2026 · strength 0.63
- Paper NECTIN4 (PVRL4) expression in pancreatic cancer patients might be associated with a more unfavorable prognosis, indepen… DOI 10.1016/j.compbiolchem.2026.109306 ↗
Durmuş Ayan · 1 shared paper, 2026 · strength 0.63
- Paper Exploratory Multi-Platform Bioinformatic Analysis of MEAK7 and Its Molecular, Survival, and Immune Associations in Panc… DOI 10.3390/ijms27177610 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.